News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

Symbiosis is celebrating…

This month Symbiosis is celebrating its 2nd anniversary.As you can see from the photos below, we’ve come a long way!After listening to our clients we have developed a business that is focused on their needs.We have transformed a building site into a world class sterile manufacturing facility, been granted our GMP license and expanded our team to 20.Most importantly we have developed… Read More

Another successful regulatory milestone achieved

Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA, in early 2012, Symbiosis hosted its first full MHRA cGMP inspection in December 2012.Not surprisingly, we are delighted to share with you that the inspection was successfully concluded to the satisfaction of the MHRA.This is another significant achievement for Symbiosis and is… Read More

Symbiosis opens contract injectables plant for early phase

“Our objective is to actively and aggressively drive down the amount of highly valuable drug development time”, Colin Mackay, Founder and CEORead the full story here :http://www.outsourcing-pharma.com/Contract-Manufacturing/Symbiosis-opens-contract-injectables-plant-for-early-phase

Symbiosis launches multi-million pound sterile drug manufacturing capability in Scotland

Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish). Symbiosis has successfully completed clinical trial manufacturing projects with clients from across Europe and Asia, including Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) and Encap Drug Delivery. The UK Government regulator, the… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.